Predictions
Virbac S.A.
Start price
Target price
Perf. (%)
€401.50
07.11.21
07.11.21
€385.00
07.11.22
07.11.22
-38.36%
22.10.22
22.10.22
Could be worthwhile Investment >10% per year
Transgene S.A.
Start price
Target price
Perf. (%)
€2.43
07.11.21
07.11.21
€2.80
07.11.22
07.11.22
-20.58%
08.11.22
08.11.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.59
31.10.21
31.10.21
€30.00
31.10.22
31.10.22
8.63%
13.11.21
13.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Virbac S.A.
Start price
Target price
Perf. (%)
€395.50
25.10.21
25.10.21
€480.00
25.10.22
25.10.22
1.52%
07.11.21
07.11.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€5.86
07.10.21
07.10.21
€7.50
07.10.22
07.10.22
-8.28%
24.11.21
24.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Nicox S.A.
Start price
Target price
Perf. (%)
€3.19
29.09.21
29.09.21
€3.80
29.09.22
29.09.22
-46.37%
30.09.22
30.09.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Valneva SE
Start price
Target price
Perf. (%)
€11.82
14.09.21
14.09.21
€30.00
14.09.22
14.09.22
-29.36%
15.09.22
15.09.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Standard Investments for future growth
Valneva SE
Start price
Target price
Perf. (%)
€11.84
13.09.21
13.09.21
-
13.09.22
13.09.22
139.19%
29.11.21
29.11.21
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Valneva SE
Start price
Target price
Perf. (%)
€12.34
13.09.21
13.09.21
€9.00
13.09.22
13.09.22
100.65%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Inventiva SA
Start price
Target price
Perf. (%)
€11.54
10.09.21
10.09.21
€8.00
10.09.22
10.09.22
-63.65%
11.09.22
11.09.22
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€3.20
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€3.20
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€20.18
03.09.21
03.09.21
€30.00
03.09.22
03.09.22
-59.38%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business
Valneva SE
Start price
Target price
Perf. (%)
€13.84
25.08.21
25.08.21
-
25.08.22
25.08.22
-32.23%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€5.10
30.07.21
30.07.21
-
30.07.22
30.07.22
2.55%
08.08.21
08.08.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet